Michigan Adrenal Group
Dr. Richard Auchus, MD, PhD
Professor of Internal Medicine, Division of Metabolism, Endocrinology & Diabetes (MEND). He received his medical degree and Ph.D. in pharmacology from Washington University in St. Louis. Dr. Auchus completed his residency at the University of Iowa and an endocrinology fellowship at UTHSC-San Antonio/Wilford Hall Medical Center. Dr. Auchus came to the University of Michigan from University of Texas, Southwestern Medical School, where he was a Professor of Internal Medicine - Endocrinology.
Dr. Auchus is a steroid biologist with expertise both in basic science and clinical/translational science. His work has included translational research into: molecular and genetic mechanisms of human hypertension, improved diagnostic studies and management in primary aldosteronism and Cushing syndromes, modifier genes in 21-hydroxylase deficiency, cardiovascular disease in polycystic ovary syndrome, and the endocrinology of traumatic brain injury.
Dr. William Rainey, PhD
Dr. Tobias Else, MD
Assistant Professor of Internal Medicine, Division of Metabolism, Endocrinology & Diabetes (MEND). He received his medical degree at the University of Hamburg, Germany, and he completed his residency and fellowship at the University of Michigan. He was the organizer and is now the director of the Michigan Endocrine Oncology Repository (MEOR). His research program focuses on adrenal cancer, both adrenocortical cancer and pheochromocytoma. In addition, he is working to define genetic causes of familial hyperaldosteronism. His research is funded by private foundations as well as the American Heart Association and National Institutes of Health.
Dr. Gary Hammer, MD, PhD
Medical endocrinologist specializing in the treatment of adrenal and gonadal diseases. Work in his laboratory has focused on the mechanisms by which signaling and transcriptional programs initiate adrenal-specific growth and differentiation with an emphasis on the dysregulated growth of adrenocortical stem cells in development and cancer.
Dr. Hammer's research focuses on the molecular underpinnings of adrenocortical growth in development and cancer. His laboratory's goals are to characterize the adrenocortical stem/progenitor cell population and elucidate how altered regulation of these cells contributes to adrenocortical disease, namely hypoplasias, dysplasias and cancer.
Dr. Thomas J. Giordano, MD, PhD
Henry Clay Bryant Professor of Pathology, Endocrine Pathology
Director, Division of Molecular and Genomic Pathology
Program Director, Surgical Pathology Fellowship
Department of Pathology
University of Michigan
Dr. Anand Vaidya, MD
Director, Center for Adrenal Disorders
Associate Professor of Medicine, Harvard Medical School
Endocrinology, Diabetes and Hypertension
Dr. Robert M. Carey, MD, M.A.C.P.
Dr. Celso Gomez-Sanchez, MD
University of Mississippi Medical Center, Jackson, Mississippi
Dr. Fumitoshi Satoh, MD, PhD
He received an M.D. in 1991 and a Ph.D. in 1997 both from Tohoku University. He completed a Research fellowship in the Department of Metabolic Medicine, Hammersmith Hospital, Imperial College of London, UK (Professor S.R. Bloom). Dr. Satoh is currently Professor; Division of Division of Nephrology, Endocrinology, and Vascular Medicine, Tohoku University Hospital. His lab